Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | SLC5A2 | P31639 | 6/20 | 0.55 |
| ▸ | TYR | P14679 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004201 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL869516 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL3727695 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL1228083 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL14974652 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL23479818 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL3742958 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL8654258 | 1.00 | CD209 (0.70) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL3759094 | 0.99 | CD209 (0.67) | CD209ATMSLC28A3EPHX2SLC5A2 | |
| SCHEMBL3739971 | 0.99 | CD209 (0.67) | CD209ATMSLC28A3EPHX2SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6764832-B2 | COMPOSITION FOR USE IN THE DETECTION OF SHIGELLA IN SAMPLE | R&F PRODUCTS, INC. | 2004-07-20 | — | — | US | claimed |
| US-20030049718-A1 | Plating media for the presumptive identification of the genus Shigella and the species Shigella sonnei and shigella boydii | R&F PRODUCTS, INC. | 2003-03-13 | — | — | US | claimed |
| EP-0122023-A1 | Microorganisms detection methods and the separation of agglutinated microorganisms, and a kit for use therein | E-Y LABORATORIES, INC. (US) | 1984-10-17 | — | — | EP | claimed |
| US-11773127-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| US-11773127-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| US-20210171563-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | WASHINGTON UNIVERSITY (US) | 2021-06-10 | — | — | US | disclosed |
| EP-2798076-B1 | METHOD OF DETECTING A SALMONELLA MICROORGANISM | 3M INNOVATIVE PROPERTIES CO (US) | 2019-04-10 | — | — | EP | disclosed |
| US-9920350-B2 | Method of detecting a salmonella microorganism | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-03-20 | — | — | US | disclosed |
| US-9879214-B2 | Method and culture device for detecting yeasts and molds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-01-30 | — | — | US | disclosed |
| US-20160032231-A1 | METHOD AND CULTURE DEVICE FOR DETECTING YEASTS AND MOLDS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2016-02-04 | — | — | US | disclosed |
| US-20150031075-A1 | METHOD OF DETECTING A SALMONELLA MICROORGANISM | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2015-01-29 | — | — | US | disclosed |
| WO-1997027320-A1 | ASSAYS USING CROSS-LINKED POLYPEPTIDE FRAGMENTS OF β-GALACTOSIDASE | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0745719-A2 | Use of carbohydrate compounds as auxiliary agents in the dyeing or printing of fibrous materials | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-12-04 | — | — | EP | disclosed |
| EP-0618974-A1 | A METHOD OF CLONING PROTEINS IN YEAST AND CELLULASE FROM HUMICOLA INSOLENS | NOVO NORDISK A/S (DK) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993011249-A1 | A METHOD OF CLONING PROTEINS IN YEAST AND CELLULASE FROM HUMICOLA INSOLENS | NOVO NORDISK A/S (DK) | 1993-06-10 | — | — | WO | disclosed |
| US-5196478-A | Polystyrene, assays | EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) | 1993-03-23 | — | — | US | disclosed |
| EP-0439585-A1 | IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS. | EPIPHARM ALLERGIE SERVICE (AT) | 1991-08-07 | — | — | EP | disclosed |
| WO-1991002768-A1 | IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS | EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) | 1991-03-07 | — | — | WO | disclosed |
| EP-0350808-A2 | Method for detecting substances with hydrolase activity | Roche Diagnostics GmbH (DE) | 1990-01-17 | — | — | EP | disclosed |
| EP-0122023-A1 | Microorganisms detection methods and the separation of agglutinated microorganisms, and a kit for use therein | E-Y LABORATORIES, INC. (US) | 1984-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171563-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | MMP8, ELANE, MPO | CD209 116/4885ATM 4382/4885SLC28A3 2992/4885 |
| US-11773127-B2 | Compounds and methods for treating bacterial infections | MMP8, ELANE, MPO | CD209 116/4885ATM 4382/4885SLC28A3 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.